Around 140 scientists gathered in Rungstedgaard, north of Copenhagen, Denmark, May 5–9 for the biannual Brain Conference organised by the Federation of European Neuroscience Societies and the Lundbeck Foundation. This article from the Alz Forum shares news from the event.
Though it carries nary a human transgene, a new mouse model developed many of the hallmark features of Alzheimer’s disease, according to a study published August 14 in Science Advances. Review shared from the Alz Forum.
At the virtual AAT-AD/PD Focus meeting, clinicians and funders involved in the DIAN-TU Trial fired up their home computers to discuss results from the first DIAN-TU treatment and prevention trial of Eli Lilly’s monoclonal antibody solanezumab, and Roche’s gantenerumab.
At this week’s virtual Alzheimer’s Association International Conference (AAIC), two reports drew attention by turning on its head the field’s emerging research trend suggesting that systemic infections could help trigger Alzheimer’s pathology in the brain.